UnitedHealth Group is a prominent player in the healthcare industry, offering a diverse range of services. With a robust presence across multiple segments like UnitedHealthcare and Optum, it caters to various consumer needs. This makes UNH a stock with steady growth potential.
The current fundamental ratings suggest a solid but not outstanding strength in various core financial metrics.
| Category | Score | Visualization |
|---|---|---|
| Overall | 3 | |
| Discounted Cash Flow | 4 | |
| Return on Equity | 4 | |
| Return on Assets | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 3 |
Comparing recent scores with past data highlights consistency in performance metrics.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-05-28 | 3 | 4 | 4 | 4 | 1 | 2 | 3 |
| Previous | 0 | 4 | 4 | 4 | 1 | 2 | 3 |
The range of analyst price targets indicates a positive future outlook for potential stock appreciation.
| High | Low | Median | Consensus |
|---|---|---|---|
| 492 | 345 | 398 | 408 |
The current sentiment among analysts reflects a generally positive perspective with a strong consensus towards buying.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 42 | |
| Hold | 6 | |
| Sell | 4 | |
| Strong Sell | 0 |
UnitedHealth Group Incorporated is well-positioned within the healthcare sector, with stable fundamental performance and positive analyst sentiment. Its diversified segment operations mitigate risks and support steady revenue streams. However, the high debt-to-equity ratio could raise concerns limiting flexibility in adverse conditions. Overall, UNH continues to be an attractive option for investors seeking growth in a resilient industry.
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.